Anti-Mouse CD22 – DyLight® 550
Anti-Mouse CD22 – DyLight® 550
Product No.: C2365
- -
- -
Clone Cy34.1 Target CD22 Formats AvailableView All Product Type Monoclonal Antibody Alternate Names Lyb-8.2 Isotype IgG1 Applications FC |
- -
- -
Antibody DetailsProduct DetailsReactive Species Mouse Host Species Mouse Immunogen Mouse B10.D2 Spleen Cells Product Concentration 0.2 mg/ml Formulation This DyLight® 550 conjugate is formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.4, 1% BSA and 0.09% sodium azide as a preservative. Storage and Handling This DyLight® 550 conjugate is stable when stored at 2-8°C. Do not freeze. Country of Origin USA Shipping Next Day 2-8°C Excitation Laser Yellow Laser (563 nm) RRIDAB_2829458 Applications and Recommended Usage? Quality Tested by Leinco FC The suggested concentration for this Cy34.1 antibody for staining cells in flow cytometry is ≤ 1.0 μg per 106 cells in a volume of 100 μl. Titration of the reagent is recommended for optimal performance for each application. Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change. DescriptionSpecificity Mouse Anti-Mouse CD22 (Clone Cy34.1) recognizes an epitope on Mouse CD22. This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype. Ligand/Receptor Associates with SHP-1, Syk, Lck, Lyn and others. PubMed NCBI Gene Bank ID UniProt.org Research Area Immunology References & CitationsTechnical ProtocolsCertificate of Analysis |
Related Products
- -
- -
Prod No. | Description |
---|---|
C1960 | |
C1958 | |
C2364 | |
C2365 | |
C2366 | |
C2367 | |
C2361 | |
C2362 | |
C2148 | |
C2359 | |
C2360 |
Formats Available
- -
- -
Prod No. | Description |
---|---|
C2364 | |
C2365 | |
C2366 | |
C2367 | |
C3358 | |
C2361 | |
C2362 | |
C2148 | |
C2359 | |
C2360 | |
C4358 |
Products are for research use only. Not for use in diagnostic or therapeutic procedures.